Apimeds Pharmaceuticals US APUS
NYSE APUS
$4.48 +0.09 (+2.14%)
As of: Aug 20, 2026 · 3:56 PM EDT

Apimeds Pharmaceuticals US (APUS) Change in Cash (2024 - 2025)

Apimeds Pharmaceuticals US's (APUS) quarterly Change in Cash came in at -$5.3 million in Q4 2025, down 23043.98% YoY from N/an in Q4 2024, and down 205.94% on a QoQ basis from -$1.7 million in Q3 2025.

Apimeds Pharmaceuticals US (APUS) Change in Cash (2024 - 2025) Analysis & Trends

Apimeds Pharmaceuticals US (APUS) has 2 years of Change in Cash data on file, last reported at -$5.3 million in Q4 2025.

  • Quarterly Change in Cash fell 23043.98% year-over-year to -$5.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.6 million (up 501.25% YoY) and the FY2025 annual result came in at $1.6 million, up 501.25% from the prior year.
  • Change in Cash retreated to -$5.3 million in Q4 2025, from -$1.7 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $8.5 million in Q2 2025 to a low of -$5.3 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn -86.00 Mn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn -465.00 Mn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn -881.03 Mn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 523.50 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn -915.70 Mn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 64.40 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 102.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Apimeds Pharmaceuticals US 7.68 Mn 7.68 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -5.35 Mn
Sep 30, 2025 -1.75 Mn
Jun 30, 2025 8.48 Mn
Mar 31, 2025 246,887.00
Dec 31, 2024 -23,116.00
Sep 30, 2024 -36,755.00
Jun 30, 2024 -84,055.00
Mar 31, 2024 -263,100.00